{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:29:21Z","timestamp":1762252161732},"reference-count":36,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/ijo.2015.2822","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T10:56:00Z","timestamp":1420714560000},"page":"1295-1303","source":"Crossref","is-referenced-by-count":10,"title":["Adenovirus-mediated ING4\/PTEN double tumor suppressor gene co-transfer modified by RGD enhances antitumor activity in human nasopharyngeal carcinoma cells"],"prefix":"10.3892","volume":"46","author":[{"given":"YIHONG","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JICHENG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEIHUA","family":"SHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUFENG","family":"XIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JISHENG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"key20180107183509_b1-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107183509_b2-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/CCO.0b013e3282fad846","article-title":"Advances in nasopharyngeal carcinoma","volume":"20","author":"Guigay","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"key20180107183509_b3-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.oraloncology.2007.08.003","article-title":"Nasopharyngeal carcinoma: current management, future directions and dental implications","volume":"44","author":"Agulnik","year":"2008","journal-title":"Oral Oncol"},{"key":"key20180107183509_b4-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000312","article-title":"Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments","volume":"9","author":"Tao","year":"2007","journal-title":"Expert Rev Mol Med"},{"key":"key20180107183509_b5-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1349-7006.2008.00836.x","article-title":"Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions","volume":"99","author":"Ma","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107183509_b6-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2008.00137.x","article-title":"Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature","volume":"18","author":"Schnell","year":"2008","journal-title":"Brain Pathol"},{"key":"key20180107183509_b7-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.biomaterials.2011.02.038","article-title":"Enhanced in vivo gene transfer into the placenta using RGD fiber-mutant adenovirus vector","volume":"32","author":"Katayama","year":"2011","journal-title":"Biomaterials"},{"key":"key20180107183509_b8-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/cgt.2012.64","article-title":"A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy","volume":"19","author":"Park","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"key20180107183509_b9-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4161\/cbt.11.7.14690","article-title":"Resistance of canine lymphoma cells to adenoviral infection due to reduced cell surface RGD binding integrins","volume":"11","author":"O\u2019Neill","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"key20180107183509_b10-ijo-46-03-1295","first-page":"2373","article-title":"p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity","volume":"63","author":"Shiseki","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107183509_b11-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/ijc.23790","article-title":"The new tumor suppressor genes ING: genomic structure and status in cancer","volume":"123","author":"Ythier","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180107183509_b12-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jmb.2009.12.049","article-title":"The dimeric structure and the bivalent recognition of H3K4me3 by the tumor suppressor ING4 suggests a mechanism for enhanced targeting of the HBO1 complex to chromatin","volume":"396","author":"Palacios","year":"2010","journal-title":"J Mol Biol"},{"key":"key20180107183509_b13-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/carcin\/bgn086","article-title":"Role of ING4 in human melanoma cell migration, invasion and patient survival","volume":"29","author":"Li","year":"2008","journal-title":"Carcinogenesis"},{"key":"key20180107183509_b14-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature02329","article-title":"The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis","volume":"428","author":"Garkavtsev","year":"2004","journal-title":"Nature"},{"key":"key20180107183509_b15-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00432-011-1099-5","article-title":"Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density","volume":"138","author":"Liu","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107183509_b16-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jso.23210","article-title":"Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma","volume":"107","author":"Zeng","year":"2013","journal-title":"J Surg Oncol"},{"key":"key20180107183509_b17-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/cgt.2010.67","article-title":"Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells","volume":"18","author":"Xie","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"key20180107183509_b18-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2011.11.003","article-title":"Synergistic antitumor effect of adenovirus-mediated hING4 gene therapy and (125)I radiation therapy on pancreatic cancer","volume":"316","author":"Zhao","year":"2012","journal-title":"Cancer Lett"},{"key":"key20180107183509_b19-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/cgt.2012.50","article-title":"Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy","volume":"19","author":"Ling","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"key20180107183509_b20-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"34677","DOI":"10.1074\/jbc.M606296200","article-title":"Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility","volume":"281","author":"Unoki","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107183509_b21-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"key":"key20180107183509_b22-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2010.12.005","article-title":"Non-genomic loss of PTEN function in cancer: not in my genes","volume":"32","author":"Leslie","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"key20180107183509_b23-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107183509_b24-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cub.2006.12.026","article-title":"PtdIns(3,4,5) P(3)-dependent and -independent roles for PTEN in the control of cell migration","volume":"17","author":"Leslie","year":"2007","journal-title":"Curr Biol"},{"key":"key20180107183509_b25-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"ra70","DOI":"10.1126\/scisignal.2003084","article-title":"The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells","volume":"5","author":"Putz","year":"2012","journal-title":"Sci Signal"},{"key":"key20180107183509_b26-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1234907","article-title":"A secreted PTEN phosphatase that enters cells to alter signaling and survival","volume":"341","author":"Hopkins","year":"2013","journal-title":"Science"},{"key":"key20180107183509_b27-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00666038","article-title":"Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors","volume":"36","author":"Weidner","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107183509_b28-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3748\/wjg.v7.i5.702","article-title":"Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma","volume":"7","author":"Wang","year":"2001","journal-title":"World J Gastroenterol"},{"key":"key20180107183509_b29-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cellsig.2010.01.013","article-title":"Examination of the expanding pathways for the regulation of p21 expression and activity","volume":"22","author":"Jung","year":"2010","journal-title":"Cell Signal"},{"key":"key20180107183509_b30-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4161\/cc.7.7.5637","article-title":"Switching cyclin D-Cdk4 kinase activity on and off","volume":"7","author":"Blain","year":"2008","journal-title":"Cell Cycle"},{"key":"key20180107183509_b31-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000317750","article-title":"Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2\/Bax ratio to induce apoptosis","volume":"56","author":"Zhou","year":"2010","journal-title":"Chemotherapy"},{"key":"key20180107183509_b32-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1091581811423845","article-title":"Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax\/Bcl-2 ratio and caspase-9-dependent pathway","volume":"31","author":"Lee","year":"2012","journal-title":"Int J Toxicol"},{"key":"key20180107183509_b33-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11912-012-0215-2","article-title":"Survivin in solid tumors: rationale for development of inhibitors","volume":"14","author":"Church","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"key20180107183509_b34-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrm1496","article-title":"Molecular mechanisms of caspase regulation during apoptosis","volume":"5","author":"Riedl","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107183509_b35-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107183509_b36-ijo-46-03-1295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1179\/2047773214Y.0000000130","article-title":"Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria","volume":"108","author":"Canavese","year":"2014","journal-title":"Pathog Glob Health"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.2822\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:38:28Z","timestamp":1515350308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.2822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,1,8]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/ijo.2015.2822"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.2822","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]}}}